Get the Stockscreener App
2.09
1.24%
-0.0262
Gri Bio Inc stock is traded at $2.09, with a volume of 6,621.
It is down -1.24% in the last 24 hours and up +24.40% over the past month.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
See More
Previous Close:
$2.1162
Open:
$2.03
24h Volume:
6,621
Relative Volume:
0.01
Market Cap:
$6.83M
Revenue:
-
Net Income/Loss:
$-8.26M
P/E Ratio:
-0.039
EPS:
-53.609
Net Cash Flow:
$-12.17M
1W Performance:
+4.50%
1M Performance:
+24.40%
6M Performance:
+46.15%
1Y Performance:
-81.06%
1-Day Range:
$2.03
$2.09
1-Week Range:
$1.77
$2.1497
52-Week Range:
$1.10
$16.91
Gri Bio Inc Stock (GRI) Company Profile
Name
Gri Bio Inc
Sector
Industry
Phone
(619) 400-1171
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA
Compare GRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
2.09 | 7.00M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.19 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.07 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
467.05 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
914.87 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.12 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | H.C. Wainwright | Buy |
Gri Bio Inc Stock (GRI) Latest News
Why GRI Bio Inc. stock is seen as undervaluedSell Signal & Weekly Return Optimization Alerts - Newser
GRI Bio receives Nasdaq notice for non-compliance with equity listing rule - Investing.com Australia
GRI Bio (GRI) Stock Analysis Report | Financials & Insights - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about GRI Bio Inc. stockWeekly Gains Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Stop Loss: What sentiment indicators say about GRI Bio Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - moha.gov.vn
Buy Signal: What insider trading reveals about GRI Bio Inc. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
This trade activity should not be overlooked: GRI Bio Inc (GRI) - Setenews
Wall Street analysts’ outlook for Moolec Science SA (MLEC) - Setenews
GRI Bio Inc Stock Analysis and ForecastRisk Mitigation Techniques & Rapid Capital Appreciation - earlytimes.in
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ('IPF') - ADVFN
GRI Stock Price and Chart — NASDAQ:GRI - TradingView
The growth track for GRI Bio Inc (GRI) has changed recently - Setenews
What technical charts say about GRI Bio Inc. stock2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
How GRI Bio Inc. stock benefits from strong dollarShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
GRI Bio Inc. stock daily chart insightsWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Visual analytics tools that track GRI Bio Inc. performanceBond Market & Reliable Price Breakout Signals - newser.com
How supply chain issues affect GRI Bio Inc. stock2025 Top Decliners & Daily Profit Focused Screening - newser.com
Will GRI Bio Inc. stock see insider buyingMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
Using economic indicators to assess GRI Bio Inc. potentialInsider Selling & Technical Pattern Based Buy Signals - newser.com
Will GRI Bio Inc. stock outperform value stocksJuly 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Technical analysis overview for GRI Bio Inc. stockJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
What does recent volatility data suggest for GRI Bio Inc.Quarterly Trade Summary & Verified Short-Term Plans - newser.com
GRI SEC FilingsGRI Bio 10-K, 10-Q, 8-K Forms - Stock Titan
GRI Q3 2025 Earnings Report on 11/14/2025 - MarketBeat
GRI Bio, Inc. SEC 10-Q Report - TradingView
Form 424B3 GRI Bio, Inc. - StreetInsider
GRI: Net loss rose to $9.3M YTD; cash runway extends into Q1 2026, but funding uncertainty remains - TradingView
GRI Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Analyzing net buyer seller activity in GRI Bio Inc.2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Gri Bio Inc Stock (GRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):